Lehrstuhl für Innere Medizin V

Selective H2-O Tissue Expression Reduces Risk for Graft-versus-Host Disease in an In Vivo Transplantation Model (2025) Zeun J, Bernhardt AL, Neubeck S, Lang V, Korn K, Nagel L, Kunert T, et al. Journal article Interesting Images: Endocytoscopy for In Vivo Diagnosis of Intestinal Graft-Versus-Host Disease (2025) Rath T, Orlemann T, Vitali F, Agaimy A, Mackensen A, Neurath M Journal article One CHiP to rule them all? Mechanistic insight into carfilzomib-induced lung injury with neutrophil extracellular trap formation following cellular immunotherapy (2025) Scholz JK, Stabel L, Schwingen NR, Knopf J, Flatt AS, Bäuerle T, Krause S, et al. Journal article, Medical case study Toward Noninvasive High-Resolution In Vivo pH Mapping in Brain Tumors by 31P-Informed deepCEST MRI (2025) Schüre JR, Rajput JR, Shrestha M, Deichmann R, Hattingen E, Maier A, Nagel AM, et al. Journal article BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells (2025) Müller F, Wirsching A, Hagen M, Völkl S, Tur C, Raimondo MG, Taubmann J, et al. Journal article Elevated high-density lipoprotein levels following acute graft-versus-host disease onset: a potential link to T-cell dysfunction and increased relapse risk (2025) Böttcher-Loschinski R, Karl F, Drettwan D, Wittmann J, Jacobs B, Völkl S, Bruns H, et al. Journal article MR sequence design to account for nonideal gradient performance (2025) West DJ, Glang F, Endres J, Leitão D, Zaiß M, Hajnal JV, Malik SJ Journal article Langzeitverlauf von Effizienz und Sicherheit der CD19-CAR T-Zell-Therapie beim systemischen Lupus erythematodes (2025) Taubmann J, Böltz S, Hagen M, Wirsching A, Müller F, Völkl S, Kharboutli S, et al. Journal article Detection of Microvascular Failure After Thrombectomy Directly in the Angio-Suite Using Parametric Color Coding (2025) Singer L, Sprügel M, Becker J, Lücking H, Gerner S, Schwab S, Dörfler A, Engelhorn T Journal article Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus (2025) Garantziotis P, Beretta L, Lindblom J, Moysidou GS, Nikolopoulos D, Grieshaber Bouyer R, Hagen M, et al. Journal article